Best Practice for Entering Transfers with Partial Refills Remaining
Transfer prescriptions carry a high audit risk due to the additional documentation required based on state regulations.
Entries by Sara Hathaway, PharmD
Updated COVID-19 Vaccine Attestations Plus Resource and Billing Chart on PAAS Member Portal
On March 29, 2022, the CDC and FDA issued press releases to provide updated COVID-19 vaccine recommendations.
Hackers Don’t Sleep, Your PHI is At Risk! What Are Your Safeguards?
Pharmacies, big and small, may find themselves on the probing end of a hacker’s criminal scheme designed to access and steal protected health information (PHI).
Options for DMEPOS Orders with Quantities Above Policy Limits
Medicare has strict coverage qualifications and limitations for items covered by Part B.
Are You Prepared to Prove TIRF REMS Program Compliance?
If your pharmacy dispenses Actiq®, Fentora®, Subsys®, or other medications which fall under the TIRF program, now is a good time to evaluate your compliance with all TIRF REMS requirements.
Caremark® Expands “Aberrant” Language & Restricts Bulk Purchases
As mentioned in PAAS’ December 2021 Newsline article about PBM provider manual updates, Caremark® traditionally mails a paper hardcopy of their full provider manual on even years, and only amendments on odd years. With 2022 being an even year, contracted pharmacies should have received a full paper copy of the 2022 provider manual.
Top Medications Flagged for Unauthorized Substitutions
PAAS National® analysts have repeatedly seen auditors targeting claims with potentially undocumented substitution issues. They hope to find inappropriate substitutions which may result in recoupment of the claim.
Update: Medicare Part D Mandatory e-Prescribing Requirements
armacies to the delay in enforcement of Electronic Prescriptions for Controlled Substances (EPCS) for Medicare Part D until January 1, 2022.
HIPAA Guidance Regarding COVID-19 Vaccination Status in the Workplace
On September 30th, the U.S. Department of Health and Human Services’ (HHS) Office for Civil Rights (OCR) released guidance regarding the Health Insurance Portability and Accountability Act (HIPAA) of 1996 Privacy Rule and its application to the workplace, specifically discussing the disclosure and request of COVID-19 vaccination status.
PREP Act Ninth Amendment – Overview and Audit Guidance for Subcutaneous REGEN-COV
The ninth amendment to the Public Readiness and Emergency Preparedness (PREP) Act was published in the Federal Register on September 14th, 2021, which granted pharmacists the authority to order and administer COVID-19 therapeutics and qualified pharmacy technicians and pharmacy interns to administer COVID-19 therapeutics under the supervision of a pharmacist.
